---
figid: PMC6617169__antioxidants-08-00166-g002
figtitle: Signaling pathways involved in the protective effects of tea bioactive compounds
  against cardiovascular diseases
organisms:
- Nicotiana tabacum
- Malus domestica
- Agaricus bisporus
- Camellia sinensis
- Theobroma cacao
- Cinnamomum verum
- Mus musculus
- Rattus norvegicus
- Chinchilla chinchilla
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Danio rerio
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6617169
filename: antioxidants-08-00166-g002.jpg
figlink: /pmc/articles/PMC6617169/figure/antioxidants-08-00166-f002/
number: F2
caption: 'Signaling pathways involved in the protective effects of tea bioactive compounds
  against cardiovascular diseases. Epigallocatechin-3-gallate (EGCG) reduced atherosclerosis
  by inhibiting the activation of the Notch receptor induced by oxidized-LDL. EGCG
  and epicatechin could attenuate dyslipidemia through regulating the SREBP1 pathway.
  EGCG could reduce the reactive oxygen species level in mitochondria and stabilize
  the mitochondrial membrane potential, thus attenuating cell swelling and apoptosis
  of endothelial cells. EGCG and epicatechin could reduce the apoptosis of cardiac
  cells through regulating the PI3K pathway. EGCG could protect endothelial function
  through alleviating endoplasmic reticulum stress. EGCG and catechin could elevate
  the endothelial nitric oxide synthase (eNOS), thus protecting endothelial function.
  EGCG could reduce oxidative stress by regulating the p38 MAPK and ERK1/2 pathways.
  Abbreviations: ADAM, A-Disintegrin-And-Metalloprotease; NICD, Notch intracellular
  domain; PI3K, phosphatidylinositol-3-kinase; Akt, α serine/threonine-protein kinase;
  SREBP, sterol regulatory element binding transcription factor; LXR, liver X receptor;
  RXR, retinoid X receptor; NCOA6, nuclear receptor coactivator 6; PTEN, phosphatase
  and tensin homolog; PDK, phosphoinositide dependent kinase; Nrf, nuclear factor
  E2-related factor; HO-1, heme oxygenase-1; TRPV, transient receptor potential vanilloid
  type.'
papertitle: 'Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention
  and Treatment of Cardiovascular Diseases: An Updated Review.'
reftext: Shi-Yu Cao, et al. Antioxidants (Basel). 2019 Jun;8(6):166.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9573451
figid_alias: PMC6617169__F2
figtype: Figure
redirect_from: /figures/PMC6617169__F2
ndex: 48991e48-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6617169__antioxidants-08-00166-g002.html
  '@type': Dataset
  description: 'Signaling pathways involved in the protective effects of tea bioactive
    compounds against cardiovascular diseases. Epigallocatechin-3-gallate (EGCG) reduced
    atherosclerosis by inhibiting the activation of the Notch receptor induced by
    oxidized-LDL. EGCG and epicatechin could attenuate dyslipidemia through regulating
    the SREBP1 pathway. EGCG could reduce the reactive oxygen species level in mitochondria
    and stabilize the mitochondrial membrane potential, thus attenuating cell swelling
    and apoptosis of endothelial cells. EGCG and epicatechin could reduce the apoptosis
    of cardiac cells through regulating the PI3K pathway. EGCG could protect endothelial
    function through alleviating endoplasmic reticulum stress. EGCG and catechin could
    elevate the endothelial nitric oxide synthase (eNOS), thus protecting endothelial
    function. EGCG could reduce oxidative stress by regulating the p38 MAPK and ERK1/2
    pathways. Abbreviations: ADAM, A-Disintegrin-And-Metalloprotease; NICD, Notch
    intracellular domain; PI3K, phosphatidylinositol-3-kinase; Akt, α serine/threonine-protein
    kinase; SREBP, sterol regulatory element binding transcription factor; LXR, liver
    X receptor; RXR, retinoid X receptor; NCOA6, nuclear receptor coactivator 6; PTEN,
    phosphatase and tensin homolog; PDK, phosphoinositide dependent kinase; Nrf, nuclear
    factor E2-related factor; HO-1, heme oxygenase-1; TRPV, transient receptor potential
    vanilloid type.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Pten
  - Akt1
  - Mapk8
  - Mp
  - Nos3
  - Ep300
  - Ncoa6
  - Nr1h3
  - Nr1h2
  - Alpha-re
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Cat
  - cac
  - Mip
  - Trpv6
  - Glyat
  - Trpv1
  - Bax
  - Nkx3-1
  - IGF1
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - MAPK8
  - MAPK9
  - MAPK10
  - NOS3
  - ENO4
  - EP300
  - NCOA6
  - NR1H2
  - NR1H3
  - RXRA
  - RXRB
  - RXRG
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - CAT
  - CRAT
  - GLYAT
  - TRPV1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - BAX
  - Igf1
  - Adam7
  - Notch1
  - Pik3cg
  - MIR92A-1
  - WFDC2
  - igfn1.2
  - ptenb
  - pdk2b
  - mapk8b
  - hbbe1.1
  - hbbe1.2
  - ncoa6
  - rxrga
  - rxrbb
  - rxrba
  - rxrab
  - mapk14a
  - cat
  - trpv1
  - baxa
  - Jag
  - eIF3j
  - .na.character
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - mir-92a
  - Pdk
  - Pdk1
  - Akt
  - bsk
  - tu(3)be
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Ca-alpha1T
  - ChAT
  - sv
  - Mmp1
  - EGCG
  - Catechin
  - Epicatechin
  - Epleatechin
  - homocysteine
  - dyslipidemia
  - AtherosclerosisI
---
